LE NOUVEL ALGORITHME INTELLISENSE AFIB DÉTECTE UNE ÉVENTUELLE FIBRILLATION AURICULAIRE LORS DE CHAQUE CONTRÔLE DE LA PRESSION ARTÉRIELLE, AMÉLIORANT AINSI LA DÉTECTION PRÉCOCE ET LA PRÉVENTION ÉVENTUELLE DE COMPLICATIONS GRAVES (ACTUALITÉ EN BREF) OMRON Healthcare a dévoilé une nouvelle gamme … Read the full press release
Posted in Artificial Intelligence (AI), Electronics & Machinery, France, Healthcare, Pharma & Biotech, Technology
Tagged accident vasculaire cérébral, algorithme alimenté par l’IA, algorithme Intellisense AFib, Ayumu Okada, détection de la fibrillation auriculaire alimentée par l’IA, ESC 2024, FA, fibrillation auriculaire, HRS 2024, Intellisense AFib, Lucia Prada, l’apprentissage automatique, l’autosurveillance de santé, M6 Comfort AFib, M7 Intelli IT AFib, mesure de la pression artérielle, OMRON Healthcare, patients hypertendus, pression artérielle, rythmes cardiaques irréguliers, surveillance médicale à domicile, technologies de la santé, tensiomètres, X7 smart AFib
IL NUOVO ALGORITMO INTELLISENSE AFIB RILEVA UNA POSSIBILE FIBRILLAZIONE ATRIALE AD OGNI CONTROLLO DELLA PRESSIONE SANGUIGNA, INCREMENTANDO LE POSSIBILITÀ DI RILEVAZIONE PRECOCE E PREVENZIONE DI COMPLICAZIONI POTENZIALMENTE GRAVI (NOTIZIA IN BREVE) OMRON Healthcare ha lanciato una nuova gamma di misuratori … Read the full press release
Posted in Artificial Intelligence (AI), Electronics & Machinery, Healthcare, Italy, Pharma & Biotech, Technology
Tagged AFib, algoritmo basato sull’IA, algoritmo Intellisense AFib, apparecchiature mediche, Ayumu Okada, cardiaco irregolare, cardiopatie, cardiovascolare, controllo della pressione sanguigna, embolia cerebrale cardiogena, ESC2024, fibrillazione atriale, gestione della salute, HRS2024, ictus, Intellisense AFib, l'apprendimento automatico, Lucia Prada, M6 Comfort AFib, M7 Intelli IT AFib, malattie cardiache, misuratori della pressione, monitoraggio della salute a domicilio, OMRON Healthcare, pazienti ipertesi, pressione sanguigna, Rilevamento AFib, rilevamento della fibrillazione atriale, rilevamento della fibrillazione atriale (AFib) basata sull’IA, rilevare una possibile fibrillazione atriale, ritmi cardiaci irregolari, tecnologia a scopo sanitario, tecnologia Intellisense AFib, X7 smart AFib, zero cardiovascolari, zero malattie cerebrovascolari
EL NUEVO ALGORITMO AFIB INTELLISENSE DETECTA UNA POSIBLE FIBRILACIÓN AURICULAR EN CADA CONTROL DE PRESIÓN, MEJORANDO LA DETECCIÓN TEMPRANA Y LA POSIBLE PREVENCIÓN DE COMPLICACIONES GRAVES (NOTICIA EN BREVE) OMRON Healthcare ha lanzado nuevos tensiómetros equipados con tecnología de detección … Read the full press release
Posted in Artificial Intelligence (AI), Electronics & Machinery, Healthcare, News, Pharma & Biotech, Spain, Technology
Tagged accidente cerebrovascular, accidente cerebrovascular cardioembólico, AFib Intellisense, algoritmo de Intellisense AFib, aprendizaje automático, autocontrol, Ayumu Okada, cardíacas, cardiopatías, cero cardiovasculares, cero enfermedades cerebrovasculares, control de la salud, control domiciliario de la salud, detección de fibrilación auricular, ESC2024, FA, fibrilación auricular, hipertensión, HRS2024, IA, Inteligencia artificial, Intellisense AFib, interrupciones en el pulso específicas de la FA, la gestión de afecciones cardiovasculares, la monitorización remota de pacientes, la Sra. Lucia Prada, latido irregular, los cuidados respiratorios, los dispositivos de terapia del dolor, M6 Comfort AFib, M7 Intelli IT AFib, OMRON, OMRON Healthcare, ritmo cardíaco irregular, tecnología médica, tensiómetros, tension, X7 smart AFib
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
